Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia

At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt, Germany) discusses a Trial of the European Working Group for Adult ALL (EWALL-PH-02), which evluated nilotinib and chemotherapy for first-line treatment in elderly patients with de novo Philadelphia chromosome/BCR-ABL1-positive acute lymphoblastic leukaemia.

Year of Production:
Running Time:
Color/Sound:

2014
06:40
Color/Sound

Comments are closed.